Acelyrin Statistics

Total Valuation

Acelyrin has a market cap or net worth of $693.19 million. The enterprise value is $1.43 million.

Market Cap	693.19M
Enterprise Value	1.43M

Important Dates

The next estimated earnings date is Monday, August 12, 2024, after market close.

Earnings Date	Aug 12, 2024
Ex-Dividend Date	n/a

Share Statistics

Acelyrin has 99.03 million shares outstanding. The number of shares has increased by 377.81% in one year.

Shares Outstanding	99.03M
Shares Change (YoY)	+377.81%
Shares Change (QoQ)	+39.38%
Owned by Insiders (%)	8.14%
Owned by Institutions (%)	107.07%
Float	58.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.05
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.27, with a Debt / Equity ratio of 0.00.

Current Ratio	13.27
Quick Ratio	n/a
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -33.90% and return on invested capital (ROIC) is -50.37%.

Return on Equity (ROE)	-33.90%
Return on Assets (ROA)	-31.20%
Return on Capital (ROIC)	-50.37%
Revenue Per Employee	n/a
Profits Per Employee	-$1.78M
Employee Count	135
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -70.81% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-70.81%
50-Day Moving Average	4.85
200-Day Moving Average	6.74
Relative Strength Index (RSI)	71.69
Average Volume (20 Days)	1,144,792

Short Selling Information

The latest short interest is 6.81 million, so 6.87% of the outstanding shares have been sold short.

Short Interest	6.81M
Short Previous Month	7.09M
Short % of Shares Out	6.87%
Short % of Float	11.59%
Short Ratio (days to cover)	6.94

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-325.01M
Pretax Income	-240.16M
Net Income	-240.16M
EBITDA	-239.81M
EBIT	-240.16M
Earnings Per Share (EPS)	-$2.38

Full Income Statement

Balance Sheet

The company has $678.54 million in cash and $1.13 million in debt, giving a net cash position of $677.40 million or $6.84 per share.

Cash & Cash Equivalents	678.54M
Total Debt	1.13M
Net Cash	677.40M
Net Cash Per Share	$6.84
Equity (Book Value)	644.07M
Book Value Per Share	6.50
Working Capital	641.70M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$201.68 million and capital expenditures $4.89 million, giving a free cash flow of -$196.79 million.

Operating Cash Flow	-201.68M
Capital Expenditures	4.89M
Free Cash Flow	-196.79M
FCF Per Share	-$2.01

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Acelyrin does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-377.81%
Shareholder Yield	-377.81%
Earnings Yield	-35.38%
FCF Yield	-28.99%

Analyst Forecast

The average price target for Acelyrin is $12.80, which is 82.86% higher than the current price. The consensus rating is "Buy".

Price Target	$12.80
Price Target Difference	82.86%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-61.09%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3